Press Releases Liquidia Corporation

Equities

LQDA

US53635D2027

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-26 pm EDT			5-day change	1st Jan Change
12.53 ^USD	+1.29%		-5.72%	+4.16%

Apr. 01	Liquidia Says US FDA Cleared to Approve Yutrepia to Treat Hypertension	MT
Apr. 01	Liquidia's Yutrepia Cleared for Potential FDA Approval Following Court Ruling	DJ

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Liquidia Corporation to Present at 23rd Annual Needham Virtual Healthcare Conference	Apr. 02	GL
Liquidia Corporation to Present at 23rd Annual Needham Virtual Healthcare Conference	Apr. 02	AQ
Update on Favorable Legal and Regulatory Outcomes Clearing Path for Potential FDA approval of YUTREPIA™ (treprostinil) inhalation powder	Apr. 01	GL
Liquidia Corporation Reports Full Year 2023 Financial Results and Provides Corporate Update	Mar. 13	GL
Liquidia Corporation to Report Full Year 2023 Financial Results on Wednesday, March 13, 2024	Mar. 06	GL
Spotlight On Upcoming Oral Arguments – February 2024	Feb. 13	AQ
Liquidia Corporation Announces Poster Presentation at the Pulmonary Vascular Research Institute 2024 Annual Congress	Jan. 30	GL
Liquidia Corporation Provides Update on New Drug Application for YUTREPIA inhalation powder	Jan. 26	AQ
Liquidia Corporation Provides Update on New Drug Application for YUTREPIA™ (treprostinil) inhalation powder	Jan. 25	GL
Liquidia Corporation Announces Updates to Operations Leadership	Jan. 19	GL
Liquidia Corporation Files Response to United Therapeutics Lawsuit and Files Counterclaims	Jan. 08	GL
Liquidia Provides Update on Clinical Pipeline Targeting PAH and PH-ILD	Jan. 05	GL
Liquidia Corporation Announces $100 Million in New Financings	Jan. 04	GL
Federal Circuit Evaluates Impact Of The Final Written Decision (FWD) In A Parallel Inter-Partes Review (IPR) On District Court's Decision Of Invalidity And Infringement	Jan. 02	AQ
Liquidia Corporation to Present at 42nd Annual J.P. Morgan Healthcare Conference	Jan. 02	GL
U.S. Federal Circuit Affirms Earlier PTAB Decision to Invalidate All Claims of United Therapeutics Patent No. 10,716,793 (‘793 Patent)	Dec. 20	GL
U.S. Federal Circuit Affirms Earlier PTAB Decision to Invalidate All Claims of United Therapeutics Patent No. 10,716,793 (‘793 Patent)	Dec. 20	AQ
Liquidia Announces Pricing of Public Offering of Common Stock	Dec. 12	GL
Liquidia Corporation Reports Third Quarter 2023 Financial Results and Provides Corporate Update	Nov. 07	GL
Liquidia Corporation to Report Third Quarter 2023 Financial Results on November 7, 2023	23-10-31	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Liquidia Corporation

Equities

LQDA

US53635D2027

Press Releases

Filters